SEC Filing Details

Document Details

Form
Filing Date
Mar 19, 2018
Document Date
Mar 15, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Altimmune, Inc.
Issuer
PHARMATHENE, INC
Filer
NOVARTIS AG

Investor Contact

Ashley Robinson
LifeSci Advisors, LLC

Email: arr@lifesciadvisors.com

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe